Injectable Drug Delivery Conference 2025 in London, Great Britain

SMi is proud to present the Injectable Drug Delivery Conference, the third annual injectable drug delivery conference in London.

As part of Europe’s leading injectables conference series, we will assess innovations in drug and biologics development, innovations in device development, quality management and connectivity to improve subcutaneous delivery.

With the rapid development of the parenteral space, the injection drug delivery market will reach US$902.3 billion by 2027, with increased emphasis on patient-centricity during DDC development, innovation in device development, including new therapeutic applications including siRNA delivery – This year’s event will focus on advances in drug development and innovation in the design and development of point-of-care devices.

Additionally, this year’s event will assess the evolving regulatory framework for injection drug delivery, with industry representatives and regulators providing updates on current guidelines.

This two-day agenda offers you a peer-to-peer network with global product managers, device testing managers, senior device engineers, device development managers, drug formulation and process development managers, and many more.

Experienced Booth Builder for your Participation at Injectable Drug Delivery Conference